Community Trust & Investment’s Teva Pharmaceuticals TEVA Stock Holding History

Community Trust & Investment’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-26,675	Closed	-$469K	–	100
2017 Q3	$469K	Hold	26,675	–	–	0.05%	83
2017 Q2	$886K	Hold	26,675	–	–	0.1%	62
2017 Q1	$856K	Hold	26,675	–	–	0.1%	64
2016 Q4	$967K	Hold	26,675	–	–	0.12%	63
2016 Q3	$1.23M	Hold	26,675	–	–	0.16%	61
2016 Q2	$1.34M	Hold	26,675	–	–	0.17%	58
2016 Q1	$1.43M	Hold	26,675	–	–	0.18%	52
2015 Q4	$1.75M	Hold	26,675	–	–	0.23%	53
2015 Q3	$1.51M	Sell	26,675 -1,319	-5%	-$85.5K	0.2%	55
2015 Q2	$1.65M	Hold	27,994	–	–	0.22%	55
2015 Q1	$1.74M	Hold	27,994	–	–	0.23%	52
2014 Q4	$1.61M	Sell	27,994 -141	-0.5%	-$7.86K	0.22%	49
2014 Q3	$1.51M	Buy	28,135 +458	+2%	+$24.3K	0.22%	48
2014 Q2	$1.45M	Buy	+27,677	New	+$1.41M	0.22%	47
2014 Q1	–	Sell	-313,119	Closed	-$12.6M	–	80
2013 Q4	$12.6M	Buy	313,119 +16,534	+6%	+$651K	2.31%	19
2013 Q3	$11.2M	Buy	296,585 +35,813	+14%	+$1.4M	2.29%	19
2013 Q2	$10.2M	Buy	+260,772	New	+$10.2M	2.17%	16

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Community Trust & Investment's TEVA Position: Q4 2017 in Review

Community Trust & Investment sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 26,675 shares — an estimated $469K sold.

Community Trust & Investment first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $12.6M in Q4 2013. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

Community Trust & Investment reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Community Trust & Investment sold 26,675 Teva Pharmaceuticals shares in Q4 2017, an estimated $469K.
Community Trust & Investment first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
Community Trust & Investment's Teva Pharmaceuticals position peaked at $12.6M in Q4 2013.
507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Community Trust & Investment's 13F filing for Q4 2017, filed 26 Jan 2018.